Ajoene, an experimental anti-leukemic drug: mechanism of cell death

被引:0
|
作者
VM Dirsch
DSM Antlsperger
H Hentze
AM Vollmar
机构
[1] Center of Drug Research,Department of Pharmacy
[2] University of Munich,undefined
[3] Biochemical Pharmacology,undefined
[4] University of Konstanz,undefined
[5] Institute of Molecular and Cell Biology (IMBC),undefined
来源
Leukemia | 2002年 / 16卷
关键词
apoptosis; organosulfur compound; caspases; mitochondria; HL-60;
D O I
暂无
中图分类号
学科分类号
摘要
The organosulfur compound ajoene, a constitutent of garlic, has been shown to induce apoptosis in a leukemic cell line as well as in blood cells of a leukemic patient. The mechanisms of action of ajoene, however, are unknown. The present study aims to characterize the molecular events leading to ajoene-triggered apoptosis. We show here that ajoene (20 μM) leads to a time-dependent activation of caspase-3-like activity as well as to the proteolytic processing of procaspase-3 and -8. Activation of caspases was necessary for ajoene-induced apoptosis since the broad-range caspase inhibitor zVAD-fmk completely abrogated ajoene-mediated DNA fragmentation. Although the initiator caspase-8 was activated, the CD95 death receptor was not involved in death signaling since the HL-60 clone used was shown to express a functionally inactive CD95 receptor. Furthermore, ajoene induced the release of cytochrome c, which was not inhibited by zVAD-fmk indicating that cytochrome c release precedes caspase activation. Ajoene also led to a dissipation of the mitochondrial transmembrane potential. Overexpression of Bcl-xL clearly diminished ajoene-induced caspase activation as well as apoptosis. These results indicate that apoptosis in leukemia cells triggered by ajoene is based on the activation of a mitochondria-dependent caspase cascade which includes also the activation of the initiator caspase-8.
引用
收藏
页码:74 / 83
页数:9
相关论文
共 50 条
  • [31] Anti-Leukemic Property of Sulphoraphane In Precursor B Cell Acute Lymphoblastic Leukemia
    Suppipat, Koramit
    Zhu, Xiao
    Park, Chun Shik
    Lacorazza, H. Daniel
    BLOOD, 2010, 116 (21) : 1620 - 1621
  • [32] Fluorescence and circular dichroism studies on binding and conformational aspects of an anti-leukemic drug with DNA
    Ashwini H. Hegde
    J. Seetharamappa
    Molecular Biology Reports, 2014, 41 : 67 - 71
  • [33] MECHANISM OF ACTION OF 2-HALOETHYLNITROSOUREAS ON DNA AND ITS RELATION TO THEIR ANTI-LEUKEMIC PROPERTIES
    LOWN, JW
    MCLAUGHLIN, LW
    CHANG, YM
    BIOORGANIC CHEMISTRY, 1978, 7 (01) : 97 - 110
  • [34] Established Human Cell Lines as Models to Study Anti-leukemic Effects of Flavonoids
    Sak, Katrin
    Everaus, Hele
    CURRENT GENOMICS, 2017, 18 (01) : 3 - 26
  • [35] CELL-KINETICS AND ANTI-LEUKEMIC EFFECT OF VINCRISTINE AND ARA-C
    SONNEVELD, P
    AGLIETTA, M
    CELL AND TISSUE KINETICS, 1979, 12 (06): : 690 - 690
  • [37] PREPARATION OF ANTI-LEUKEMIC T-CELL IMMUNOLIPOSOMES AND THEIR TARGET SPECIFIC PROPERTIES
    褚嘉佑
    吴旻
    沈子威
    赵南明
    ChineseScienceBulletin, 1992, (18) : 1561 - 1564
  • [38] Anti-leukemic properties of deferasirox via apoptosis in murine leukemia cell lines
    Jeon, Sol-Rim
    Lee, Jae-Wook
    Jang, Pil-Sang
    Chung, Nack-Gyun
    Cho, Bin
    Jeong, Dae-Chul
    BLOOD RESEARCH, 2015, 50 (01) : 33 - 39
  • [39] Anti-leukemic activity of bortezomib and carfilzomib on B-cell precursor ALL cell lines
    Takahashi, Kazuya
    Inukai, Takeshi
    Imamura, Toshihiko
    Yano, Mio
    Tomoyasu, Chihiro
    Lucas, David M.
    Nemoto, Atsushi
    Sato, Hiroki
    Huang, Meixian
    Abe, Masako
    Kagami, Keiko
    Shinohara, Tamao
    Watanabe, Atsushi
    Somazu, Shinpei
    Oshiro, Hiroko
    Akahane, Koshi
    Goi, Kumiko
    Kikuchi, Jiro
    Furukawa, Yusuke
    Goto, Hiroaki
    Minegishi, Masayoshi
    Iwamoto, Shotaro
    Sugita, Kanji
    PLOS ONE, 2017, 12 (12):
  • [40] Effects of plant-derived anti-leukemic drugs on individualized leukemic cell population profiles in Egyptian patients
    Aboul-Soud, Mourad A. M.
    El-Shemy, Hany A.
    Aboul-Enein, Khalid M.
    Mahmoud, Ali M.
    Al-Abd, Ahmed M.
    Lightfoot, David A.
    ONCOLOGY LETTERS, 2016, 11 (01) : 642 - 648